• Thumbnail for Novavax COVID-19 vaccine
    The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the...
    74 KB (5,621 words) - 06:11, 21 October 2024
  • Thumbnail for Novavax
    February 2022, as the fifth vaccine against COVID-19, following Pfizer/BioNTech, Moderna, Janssen and AstraZeneca. In June 2013, Novavax acquired the Matrix-M...
    31 KB (2,866 words) - 14:32, 20 November 2024
  • authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one...
    322 KB (19,558 words) - 03:33, 16 September 2024
  • A COVID19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus...
    205 KB (23,333 words) - 06:21, 21 November 2024
  • Thumbnail for Sanofi–GSK COVID-19 vaccine
    Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID19 vaccine...
    19 KB (1,436 words) - 08:53, 24 September 2024
  • Thumbnail for Vaxart COVID-19 vaccine
    Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. "Patent Landscape Report COVID-19-related vaccines and therapeutics" (PDF)...
    2 KB (108 words) - 10:50, 24 September 2024
  • Thumbnail for Pfizer–BioNTech COVID-19 vaccine
    The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...
    260 KB (22,097 words) - 23:43, 14 October 2024
  • Thumbnail for COVID-19 vaccine misinformation and hesitancy
    variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion...
    132 KB (12,911 words) - 03:13, 18 November 2024
  • Thumbnail for COVID-19 vaccination in Singapore
    the Health Ministry concluded a purchase agreement with Novavax for its non-mRNA COVID-19 vaccine, with shipments expected to arrive in Singapore before...
    39 KB (2,991 words) - 10:55, 3 November 2024
  • Thumbnail for Oxford–AstraZeneca COVID-19 vaccine
    Oxford–AstraZeneca COVID19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was...
    214 KB (17,080 words) - 15:51, 27 September 2024
  • Thumbnail for History of COVID-19 vaccine development
    NVX-CoV2373, a COVID19 vaccine being developed by Novavax CZ AS (a subsidiary of Novavax, Inc.) and a rolling review of CVnCoV, a COVID19 vaccine being developed...
    122 KB (11,033 words) - 06:12, 17 November 2024
  • Thumbnail for Janssen COVID-19 vaccine
    The Janssen COVID19 vaccine, (Ad26.COV2.S) sold under the brand name Jcovden, is a COVID19 vaccine that was developed by Janssen Vaccines in Leiden,...
    141 KB (11,331 words) - 06:12, 24 September 2024
  • Thumbnail for COVID-19 vaccine clinical research
    COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy...
    98 KB (19,258 words) - 11:27, 22 November 2024
  • Thumbnail for Sputnik V COVID-19 vaccine
    Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed...
    154 KB (13,917 words) - 19:29, 18 November 2024
  • Moderna, Sinopharm BIBP, Sputnik Light and Novavax. As of February 19, 2023, 166,423,405 total vaccine doses have been administered throughout the country...
    128 KB (9,955 words) - 00:32, 16 August 2024
  • Thumbnail for Stemirna COVID-19 vaccine
    Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Patent Landscape Report COVID-19-related vaccines and therapeutics"...
    3 KB (113 words) - 09:01, 24 September 2024
  • Thumbnail for Sinopharm BIBP COVID-19 vaccine
    COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed...
    90 KB (8,588 words) - 08:11, 24 September 2024
  • Thumbnail for COVID-19 vaccination in Australia
    (ARTG). As of 14 June 2021, Novavax had entered the final stage of trials. As of 8 July 2021, the Novavax COVID-19 vaccine was under evaluation by the...
    177 KB (12,115 words) - 21:09, 21 November 2024
  • CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian Academy...
    8 KB (576 words) - 14:52, 20 October 2024
  • Thumbnail for Moderna COVID-19 vaccine
    The Moderna COVID19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National...
    177 KB (13,698 words) - 16:52, 23 October 2024
  • Thumbnail for Responses to the COVID-19 pandemic in March 2022
    the Novavax COVID-19 vaccine for people aged 18 and above. The first doses are expected to arrive in the country in March 2022. New Zealand COVID-19 Response...
    7 KB (495 words) - 06:49, 20 November 2024
  • Thumbnail for Chinese Academy of Medical Sciences COVID-19 vaccine
    Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute...
    4 KB (192 words) - 08:25, 24 September 2024
  • Thumbnail for Inovio COVID-19 vaccine
    Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence...
    9 KB (880 words) - 06:15, 24 September 2024
  • Thumbnail for Deployment of COVID-19 vaccines
    53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having received at least one dose. While 4.19 million...
    156 KB (13,918 words) - 21:34, 29 September 2024
  • Thumbnail for Sanofi–Translate Bio COVID-19 vaccine
    The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate...
    5 KB (294 words) - 08:54, 24 September 2024
  • Thumbnail for MVC COVID-19 vaccine
    MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,...
    15 KB (1,455 words) - 06:02, 24 September 2024
  • Thumbnail for Operation Warp Speed
    Retrieved July 7, 2020. "HHS, DOD Collaborate with Novavax to Produce Millions of COVID-19 Investigational Vaccine Doses in Commercial-Scale Manufacturing Demonstration...
    71 KB (5,872 words) - 05:25, 14 November 2024
  • Thumbnail for COVID-19 vaccine hesitancy in the United States
    the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy...
    40 KB (3,771 words) - 01:07, 31 August 2024
  • Thumbnail for West China Hospital COVID-19 vaccine
    West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by West China Hospital. In August 2020, WestVac Biopharma started phase...
    4 KB (289 words) - 01:19, 13 September 2024
  • Thumbnail for COVID-19
    most COVID‑19 vaccines were two-dose vaccines, with the exception single-dose vaccines Convidecia and the Janssen COVID19 vaccine, and vaccines with three-dose...
    288 KB (33,185 words) - 16:52, 20 November 2024